Publication:
Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications

Simple item page
dc.contributor.affiliation"Université de Strasbourg, CNRS, Institut de Physique et Chimie des Matériaux de Strasbourg, UMR 7504, Strasbourg, F-67034, France"," Labex CSC, Fondation IcFRC, Université de Strasbourg, 8 allée Gaspard Monge BP 70028, Cedex, Strasbourg, F-67083, France"," Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Univ. de Zaragoza, Centro de Investigacion Biomedica en Red de Bioingenieria, Biomateriales y Nanomedicina, Zaragoza, 50018, Spain"," Department of Radiology, Medical Physics, Medical Center, University of Freiburg, Faculty of Medicine, Germany"," German Cancer Consortium (DKTK), Heidelberg, Germany"," German Cancer Research Center (DKFZ), Heidelberg, Germany"," Université de Strasbourg, INSERM, UMR 1121 Biomaterials and Bioengineering, FMTS, Strasbourg, F-67000, France"," Geophysical Centre, Royal Meteorological Institute, 1 rue du Centre Physique, Dourbes, 5670, Belgium"," Dept of Materials Science and Engineering, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4M1, Canada"," Université de Mons, General, Organic and Biomedical Chemistry Unit, NMR and Molecular Imaging Laboratory, Mons, 7000, Belgium"," Institut des Molécules et Matériaux du Mans, IMMM UMR CNRS 6283, Université du Maine, Avenue Olivier Messiaen, Cedex 9, Le Mans, 72085, France"," IMdea Nanociencia, Campus Universitario de Cantoblanco, Madrid, 28049, Spain"," Nanobiotecnología (IMdea-Nanociencia), Unidad Asociada Al Centro Nacional de Biotecnología (CSIC), Madrid, 28049, Spain"," Condensed Matter Physics Department, Faculty of Sciences, University of Cádiz, Puerto Real, 11510, Spain"," Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), Cádiz, 11009, Spain"en
dc.contributor.affiliation000000041762408X
dc.contributor.authorCotin G.
dc.contributor.authorBlanco-Andujar C.
dc.contributor.authorPerton F.
dc.contributor.authorAsín L.
dc.contributor.authorDe La Fuente J.M.
dc.contributor.authorReichardt W.
dc.contributor.authorSchaffner D.
dc.contributor.authorNgyen D.-V.
dc.contributor.authorMertz D.
dc.contributor.authorKiefer C.
dc.contributor.authorMeyer F.
dc.contributor.authorSpassov S.
dc.contributor.authorErsen O.
dc.contributor.authorChatzidakis M.
dc.contributor.authorBotton G.A.
dc.contributor.authorHénoumont C.
dc.contributor.authorLaurent S.
dc.contributor.authorGreneche J.-M.
dc.contributor.authorTerán, Francisco
dc.contributor.authorOrtega D.
dc.contributor.authorFelder-Flesch D.
dc.contributor.authorBegin-Colin S.
dc.date.accessioned2021-10-04T11:18:01Z
dc.date.available2021-10-04T11:18:01Z
dc.date.issued2021
dc.identifier.doi10.1039/d1nr03335ben
dc.identifier.urihttp://hdl.handle.net/20.500.12614/2701
dc.journal.titleNanoscaleen
dc.language.isoenen
dc.page.initial14552en
dc.relation.projectIDinfo:eu:eu-repo/grantAgreement/EC/H2020/685795/EU/Nanomedicine upscaling for early clinical phases of multimodal cancer therapy/NoCanTheren
dc.relation.projectIDTEMPThe Region Alsace, France, and the Labex Chimie des Systemes Complexes, University of Strasbourg, France are gratefully acknowledged for the doctoral fellowship to Geoffrey Cotin. This research project was also co-funded by Labex CSC, Alsace contre le cancer, INCA (project PRTK14, THERAMAG 2014-225) and the INTERREG project NANOTRANSMED. The “NANOTRANSMED” project is co-funded by the European Regional Development Fund (ERDF) and by the Swiss Confederation and the Swiss cantons of Aargau, Basel-Landschaft and Basel-Stadt, in the framework of the INTERREG V Upper Rhine program (“Transcending borders with every project”). The authors thank Morgane Rabineau for epifluorescence imaging and Nadia Messaddeq for TEM imaging of cells. The authors thank the Center for Microscopy and Molecular Imaging (CMMI, supported by the European Regional Development Fund and the Walloon Region). This work was supported by the Fond National de la Recherche Scientifique (FNRS), UIAP VII, ARC Programs of the French Community of Belgium and the Walloon region (Gadolymph and Holocancer programs). All the authors acknowledge the COST action TD1402 “RADIOMAG”. D. Ortega and F. J. Teran acknowledge support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686), the Spanish Ministry of Economy and Competitiveness for the NANOLICO project (MAT2017-85617-R), the Spanish Ministry of Science through the NaNoCAR grant PID2020-117544RB-I00, the Ramón y Cajal grant RYC2018-025253-I and Research Networks grant RED2018-102626-T, the HEATOOLS project (BIO2017-84246-C2-1-R), the Comunidad de Madrid for grant NANOMAGCOST (P2018/NMT-4321), DGA for public funding from Fondo Social (grupos DGA), and the European Commission for the funding received through the H2020 “NoCanTher” project (GA No. 685795). The authors would like to acknowledge the use of Servicios Cientifícos Técnicos del CIBA (IACS-Universidad de Zaragoza) for access to their instrumentation and expertise.
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsopen accessen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titleUnveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applicationsen
dc.typeresearch articleen
dc.volume.number13en
dspace.entity.typePublication

Files

Collections

Publications